Sandra Lara

Sandra Lara supports the Naval Medical Research Center’s mission by managing critical acquisitions in biomedical research and diagnostic innovation. She oversees the procurement of advanced laboratory technologies, in-vitro diagnostic systems, and field-deployable medical tools essential to force health protection in austere environments. Her work directly enables the development and validation of rapid pathogen detection platforms and precision monitoring solutions for Navy and Marine Corps personnel, aligning procurement strategy with the agency’s priority to enhance operational readiness through scientific advancement. She handles complex, high-technical-risk contracts requiring close collaboration with scientific staff to ensure compliance with regulatory and performance standards. Lara maintains a strong working relationship with REES SCIENTIFIC CORPORATION, a key vendor providing specialized diagnostic reagents and analytical instrumentation. Her contracting pattern reflects a preference for established technical partners with proven capabilities in life sciences manufacturing and R&D, indicating a focus on reliability and regulatory compliance over rapid vendor turnover. These partnerships are characterized by long-term engagement, technical alignment, and iterative product development cycles tailored to military medical needs. Sandra Lara’s procurement portfolio reflects a 100% non-set-aside approach, indicating a primary emphasis on technical capability and mission readiness over socioeconomic preferences. While small business participation is not formally prioritized in her award patterns, this does not preclude engagement with qualified small firms—rather, it underscores a strict merit-based selection process driven by technical superiority and regulatory readiness. Her procurement focus centers on NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing), 541712 (Life Sciences R&D), and 325411 (Medicinal and Botanical Manufacturing), reflecting deep expertise in diagnostic assay development, laboratory reagent production, and biotherapeutic formulation. She routinely procures clinical-grade reagents, biosensors, and deployable diagnostic kits, demonstrating specialized knowledge in molecular diagnostics, pathogen detection, and biomedical engineering for military applications.